FZMD · Fuse Medical, Inc.
Market Cap
$2.22M
Shares
73.90M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.03
Open$0.03
Day$0.03–0.03
52W close$0.02–0.10
Avg vol 30d39K
Short int504 · 0.0% float
Short vol39%
DataJan 2020–Sep 2026
Filing10-Q · Aug 14
Up next
filed Aug 14, 2023
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$18.40M
Trailing 12 months
Net income (TTM)
$3.98M
Trailing 12 months
Revenue growth YoY
+7.0%
Year over year
Operating margin
-0.7%
Trailing 12 months
P / E (TTM)
0.6
Trailing earnings · reciprocal yield 179.4%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+10.7%
Year over year · more shares
Price change (1Y)
-72.0%
Trailing year
Short interest
—
Latest settlement
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.47
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−74%
below
Price vs 50-day avg
−36%
below
RSI (14)
49
neutral
MACD trend
Positive
52-week position
10%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−30%
trailing
6-month return
−81%
trailing
YTD return
+40%
this year
Relative strength
−96%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Revenue growth
−0%
Y/Y
Gross margin
44%
contracting
EPS growth
+300%
Y/Y
Free cash flow
$14.0K
Quant / Vol
risk profile
Volatility
690%
annualized · 1-yr
Max drawdown
−97%
past year
ATR
26.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−74%
Bearish
Price vs 50-day avg
−36%
Bearish
RSI (14)
49
Neutral
MACD trend
Positive
Bullish
52-week position
10%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 10%
Range high $0
vs 200-day avg -74%
vs 50-day avg -36%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FZMD
this stock
Fuse Medical, Inc.
|
$2.22M | +40.0% | -0.2% | — | 0.0% |
|
ABT
Abbott Laboratories
|
$192.64B | -13.2% | +5.7% | 31.0 | 1.2% |
|
MDT
Medtronic plc
|
$118.37B | -3.1% | +8.4% | 24.8 | 1.1% |
|
SYK
Stryker Corp
|
$118.14B | -12.4% | +11.2% | 31.9 | 1.8% |
|
BSX
Boston Scientific Corp
|
$70.10B | -50.8% | +12.5% | 19.6 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FZMD | +40.0% | -30.0% | -81.3% | +21.7% | +40.0% |
| SPY | -0.1% | -0.6% | +14.9% | -0.3% | +12.2% |
| vs SPY | +40.1% | -29.4% | -96.2% | +22.0% | +27.8% |